Skip to main content
. 2024 Feb 5;16(2):235. doi: 10.3390/pharmaceutics16020235

Figure 6.

Figure 6

Confocal microscopy images of glioblastoma cells. (a,c): control cells receiving only NeutrAvidinTM and the biotinylated liposomes; (b,d): cells treated with the complete three-step protocol (NAMP-NeutrAvidinTM-biotinylated liposomes); a 2 h incubation time in (a,b), and a 4 h incubation time in (c,d).